CervoMed Inc. Accounts Payable
CervoMed Inc. (CRVO) had Accounts Payable of $687.11 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $687.11K.
- 2026-03-31: Accounts Payable, Current $2.27M.
- 2025-12-31: Accounts Payable, Current $1.45M.
- 2025-09-30: Accounts Payable, Current $1.35M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $687.11K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.27M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.45M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.35M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.85M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $1.08M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $725.85K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $679.74K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $662.47K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $533.79K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $932.43K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $971.46K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $97.30K 10-K · filed 2024-03-29 | $1.13M 10-K · filed 2023-03-24 |
| 2022-09-30 | $807.37K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $846.03K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $813.20K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $947.50K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $678.04K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $749.95K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $952.91K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $545.84K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $1.41M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.35M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $655.30K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.25M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $502.47K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $489.13K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $480.02K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $198.82K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $129.06K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $175.77K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $419.10K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $511.96K 10-K · filed 2019-03-19 | |
| 2017-09-30 | $409.42K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.04M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $557.63K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.68M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $757.47K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.01M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.12M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $424.68K 10-K · filed 2017-03-31 | $36.11K 10-K · filed 2016-03-25 |
| 2015-09-30 | $240.38K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $337.59K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $301.67K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $417.31K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $105.53K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $252.14K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.60M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $1.52M 10-K · filed 2015-04-03 | |
| 2013-09-30 | $1.54M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $1.35M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.19M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $1.20M 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $971.73K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $1.05M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $789.02K 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | $594.16K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $627.09K 10-Q · filed 2011-08-16 | |
| 2010-12-31 | $903.26K 10-K · filed 2012-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |